Lippard SJ - Search Results

1

Cisplatin and DNA repair in cancer chemotherapy.

Zamble DB, Lippard SJ. Zamble DB, et al. Among authors: lippard sj. Trends Biochem Sci. 1995 Oct;20(10):435-9. doi: 10.1016/s0968-0004(00)89095-7. Trends Biochem Sci. 1995. PMID: 8533159 Review.

2

DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.

Pilch DS, Dunham SU, Jamieson ER, Lippard SJ, Breslauer KJ. Pilch DS, et al. Among authors: lippard sj. J Mol Biol. 2000 Feb 25;296(3):803-12. doi: 10.1006/jmbi.2000.3496. J Mol Biol. 2000. PMID: 10677282

3

Enhanced binding of the TATA-binding protein to TATA boxes containing flanking cisplatin 1,2-cross-links.

Cohen SM, Jamieson ER, Lippard SJ. Cohen SM, et al. Among authors: lippard sj. Biochemistry. 2000 Jul 18;39(28):8259-65. doi: 10.1021/bi0004495. Biochemistry. 2000. PMID: 10889034

4

2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.

Spingler B, Whittington DA, Lippard SJ. Spingler B, et al. Among authors: lippard sj. Inorg Chem. 2001 Oct 22;40(22):5596-602. doi: 10.1021/ic010790t. Inorg Chem. 2001. PMID: 11599959

5

Kinetic studies of the TATA-binding protein interaction with cisplatin-modified DNA.

Jung Y, Mikata Y, Lippard SJ. Jung Y, et al. Among authors: lippard sj. J Biol Chem. 2001 Nov 23;276(47):43589-96. doi: 10.1074/jbc.M108299200. Epub 2001 Sep 21. J Biol Chem. 2001. PMID: 11568187

6

Cisplatin: from DNA damage to cancer chemotherapy.

Cohen SM, Lippard SJ. Cohen SM, et al. Among authors: lippard sj. Prog Nucleic Acid Res Mol Biol. 2001;67:93-130. doi: 10.1016/s0079-6603(01)67026-0. Prog Nucleic Acid Res Mol Biol. 2001. PMID: 11525387 Review.

7

Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins.

Mikata Y, He Q, Lippard SJ. Mikata Y, et al. Among authors: lippard sj. Biochemistry. 2001 Jun 26;40(25):7533-41. doi: 10.1021/bi010318j. Biochemistry. 2001. PMID: 11412107

8

Intercalating residues determine the mode of HMG1 domains A and B binding to cisplatin-modified DNA.

He Q, Ohndorf UM, Lippard SJ. He Q, et al. Among authors: lippard sj. Biochemistry. 2000 Nov 28;39(47):14426-35. doi: 10.1021/bi001700j. Biochemistry. 2000. PMID: 11087395

9

Stopped-flow fluorescence studies of HMG-domain protein binding to cisplatin-modified DNA.

Jamieson ER, Lippard SJ. Jamieson ER, et al. Among authors: lippard sj. Biochemistry. 2000 Jul 25;39(29):8426-38. doi: 10.1021/bi000342h. Biochemistry. 2000. PMID: 10913248

10

Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.

Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ. Ohndorf UM, et al. Among authors: lippard sj. Nature. 1999 Jun 17;399(6737):708-12. doi: 10.1038/21460. Nature. 1999. PMID: 10385126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results